Dr. Gopal Pillai received his B.Pharm and M.Pharm from Birla Institute of Technology and Science, Pilani, India and MSc and PhD from the University of British Columbia (UBC), Vancouver, BC, Canada. Dr. Pillai was on the faculty of the College of Pharmaceutical Sciences, Manipal, India, as a professor of Pharmaceutics, at the Jordan University of Science and Technology, Jordan and at the University of the West Indies, Trinidad as professor and Director of the School of Pharmacy, UWI. While in Trinidad, Dr. Pillai also served as a member of the Drug Advisory committee, Ministry of Health, Government of Trinidad & Tobago, an honorary appointment by the Minister of Health. Dr. Pillai represented Trinidad at the PAHO/WHO sponsored conference on Pharmaceutical education in the Caribbean in Barbados, Bahamas, Buenos Aires (Argentina) and Montevideo (Uruguay). Dr. Pillai supervised the research work of several post graduate students (M. Pharm&M. Phil and PhD). His research area include evaluation of surfactant vesicles as a nanomedicine carrier for targeted drug delivery of anticancer agents, anti-inflammatory agents and metal chelating agents; developing analytical methods (high resolution Gas chromatography with capillary columns, HPLC); analysis of enantiomeric mixtures for study of stereospecific drug disposition and evaluation of bioequivalence of generic drug products. He has been a recipient of several research grants from various agencies, has presented several papers in international conferences and has many publications in peer reviewed journals. Dr. Pillai served as chairman of the organizing committee for the third and fourth Annual International conference on Nanotechnology and Applications held in Sullivan University College of Pharmacy, Louisville,Kentucky and is the editor of Advances in Nanotechnology and Applications, volume 3 and 4, published by the Center for Nanotechnology Education, Research and Applications, SUCOP, Louisville, KY.
Formulation and evaluation of targeted drug delivery systems for anticancer agents and antiinflammatory agents, sustained and controlled drug delivery systems, Nanomedicines, bioequivalency evaluation of generic products, development of high resolution gas chromatographic methods for analysis of stereoisomers and its application in study of stereospecific disposition of drugs.